Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Bioprocess containers are containers system design and developed for process of manufacturing food, fed, pharmaceutical and others. In addition, single-use bioprocess containers or disposable bio manufacturing replaces stainless steel tanks, bioreactors, and plumbing with plastic, to provide flexibility, agility, and speed to the production of products. These container are widely used for cell culture products, bioprocess systems, drug discovery, and other related activities. The bioprocess containers optimize the bioprocessing approach by helping to increase the substrate range for a given cell factory. This help to reduce the cost of microbial fermentation which ultimately fuels the market growth.
The key factor for the growth is increasing demand for low cost biologics drugs as these drugs are made from complex molecules manufactured using living microorganisms, plants, or animal cells. Biologics include a variety of specialty medicines, vaccines, and insulin’s thereby increasing demand of bioprocess containers market. In addition, affordability and sustainability of single-use bioprocess technologies is boosting the growth owing to disposable aseptic connectivity which reduce the level of end-user manipulation within the process and therefore create greater safety. Also, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination has increasing demand for bioprocess containers. Beside emergence of biopharma industry in developing economies is propelling the market growth.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the bioprocess containers market. In addition, complete analysis of changes on the bioprocess containers market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 impact on the bioprocess containers market was moderate as the production and demand for bioprocess containers was decreased which has hampered the market growth.
The bioprocess containers market is segmented based on by type, by application, by end user and by geography.
The bioprocess containers are available in different types including 2 D container, 3D container and accessories. 2D bioprocess containers is expected to leads due to growing demand for bioprocess containers in biopharmaceutical industries. These contains are majorly used for fermentation feed, sampling, and harvest, Storage and transport of bulk intermediate products, process intermediates, vaccine conjugates, and other biological products. The containers also has role to speed up biopharmaceutical production process.
Bioprocess containers has major application in production process, upstream process, downstream process. Upstream process leads accounting the significant market share in bioprocess containers market. Upstream processing has the highest use of bioprocess containers for initially phase of bioprocess from development and cultivation to culture expansion of the product through harvest especially during fermentation, mixing, and culture media processing. In addition, modern cell culture systems is producing notably higher titers while decreasing the time from bench to production bioreactor.
The bioprocess containers market had its major end use in pharmaceutical companies, biotechnology companies, life science companies, biopharmaceutical companies. Biopharmaceutical companies dominates in global bioprocess containers market accounting the largest share of market. The biopharmaceutical companies has major use of newest technology advances which are combined single-use components to a single-use unit operation, which results in connection of unit operations to a potential single-use process. These single use utilization within aseptic processes provides benefits for high quality production of product without the risk of cross contamination. On the other hand life science companies is expected to grow at highest rate attributed to sustainable and green approach to the production and drive cycles of design, build, test, and learn implemented by metabolic engineers to optimize the cell factory performance which is further fueling the growth of segment in the global bioprocess containers market
Geographically the global bioprocess containers market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW). North America is anticipated to be the leading market based on geography in global bioprocess containers market due to presence of major players in the region. Whereas Europe is projected to hold the second largest position in global bioprocess containers market. In addition, increasing demand for biological products and biological drugs is fueling the growth of bioprocess containers market in the region. Moreover, Asia Pacific is projected to grow at the fastest pace owing to existence of major countries like China, India, Australia and Japan. Besides region is experienced to witness the growing demand for pharmaceutical and biotech industries.
The key players in bioprocess containers market are GE Healthcare , Merck KGaA , Thermo Fisher Scientific , Sartorius , Danaher Corporation, Lonza , Fenner PLC , Rim Bio, Fluids Control, Meissner , Parker Hannifin Corp, Neta Scientific Incorporated, Finesse Solutions,Inc. , ALLpaQ Packaging Group and Optimum Processing Inc among others.
December 2020: Thermo Fisher has introduces 500 L capacity single use bioreactor. As biopharmaceutical companies are increasingly integrate single-use-technology into processes such as perfusion and cGMP manufacturing, they are seeking scalable single-use bioreactors.
August 2018: Gore had Launched GORE STA-PURE Flexible Freeze Containers at BioProcess International Conference and Exhibition (BPI).The product is designed to protect high value bulk drug substances from container breakage or leakage during frozen handling which is the most vulnerable stage of the product’s processing to delivery. The containers are constructed of a proprietary high-strength fluoropolymer material that is durable after freezing at -86°C (-123°F).
January 2018: Parker Hannifin had announced the creation of a new division, Parker Bioscience Filtration Division. The division has sites in Birtley, UK and Oxnard, California, which will deliver international bioprocessing, food and beverage, and healthcare solutions that previously operated under the Parker domnick hunter brand.
The report analyses the global bioprocess containers market based on by type, by application, by end user and by geography. The bioprocess Containers are available in different types including 2 D container, 3D container and accessories .Bioprocess Containers has major application in production process, upstream process, downstream process. The bioprocess containers market had its major end use in pharmaceutical companies, biotechnology companies, life science companies, biopharmaceutical companies. Geographically the global bioprocess containers market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW)
The key players in bioprocess containers market are GE Healthcare , Merck KGaA , Thermo Fisher Scientific , Sartorius , Danaher Corporation, Lonza , Fenner PLC , Rim Bio, Fluids Control, Meissner , Parker Hannifin Corp, Neta Scientific Incorporated, Finesse Solutions,Inc. , ALLpaQ Packaging Group and Optimum Processing Inc among others.
Why to buy this report:
